Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer.
Saved in:
| Title: | Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer. |
|---|---|
| Authors: | Xu, Wenjing1 (AUTHOR), Li, Yingqiu2 (AUTHOR), Liu, Lumei3,4 (AUTHOR), Xie, Jing5,6 (AUTHOR), Hu, Zongren5,6 (AUTHOR), Kuang, Shida4,7 (AUTHOR), Fu, Xinying4,7 (AUTHOR), Li, Bonan3,4 (AUTHOR), Sun, Tiansong3,4 (AUTHOR), Zhu, Congxu3,4 (AUTHOR), He, Qinghu4,5,6 (AUTHOR) qinghu_he3418@hnucm.edu.cn, Sheng, Wen5,6 (AUTHOR) shengwendoctor@hnucm.edu.cn |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 5/23/2024, Vol. 43 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
